BNP and congestive heart failure

Nakao, 1992, Molecular biology and biochemistry of the natriuretic peptide system. I, J Hypertension, 10, 907 Stein, 1998, Natriuretic peptides, Am Heart J, 135, 914, 10.1016/S0002-8703(98)70054-7 Goetz, 1991, Renal natriuretic peptide (urodilatin?) and atriopeptin, Am J Physiol, 261, F921 Kangawa, 1984, Purification and complete amino acid sequence of alpha-human atrial natriuretic peptide (alpha-hANP), Biochem Biophys Res Commun, 118, 131, 10.1016/0006-291X(84)91077-5 de Bold, 1981, A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats, Life Sciences, 28, 89, 10.1016/0024-3205(81)90370-2 Levin, 1998, Natriuretic peptides, N Engl J Med, 339, 321, 10.1056/NEJM199807303390507 Holmes, 1993, Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man, J Clin Endocrinol Metab, 76, 91 Lang, 1992, Atrial and brain natriuretic peptides, Clin Sci, 83, 519, 10.1042/cs0830519 Sudoh, 1988, A new natriuretic peptide in porcine brain, Nature, 332, 78, 10.1038/332078a0 Yasue, 1994, Localisation and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure, Circulation, 90, 195, 10.1161/01.CIR.90.1.195 Mukoyama, 1991, Brain natriuretic peptide as a novel cardiac hormone in humans, J Clin Invest, 87, 1402, 10.1172/JCI115146 Hosoda, 1991, Expression of brain natriuretic peptide gene in human heart, Hypertension, 17, 1152, 10.1161/01.HYP.17.6.1152 Nakao, 1991, Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide, Can J Physiol Pharmacol, 69, 1500, 10.1139/y91-225 Sudoh, 1990, C-type natriuretic peptide (CNP), Biochem Biophys Res Commun, 168, 863, 10.1016/0006-291X(90)92401-K Ueda, 1991, Distribution and characterization of immunoreactive porcine C-type natriuretic peptide, Biochem Biophys Res Commun, 175, 759, 10.1016/0006-291X(91)91631-L Kalra, 2001, The role of C-type natriuretic peptide in cardiovascular medicine, Eur Heart J, 22, 997, 10.1053/euhj.2000.2395 Schulz-Knappe, 1988, Isolation and structural analysis of “urodilatin” a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine, Klin Wchnschr, 66, 752, 10.1007/BF01726570 Schweitz, 1992, A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps), J Biol Chem, 267, 13928, 10.1016/S0021-9258(19)49658-0 Schirger, 1999, Presence of dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure, Mayo Clin Proc, 74, 126, 10.4065/74.2.126 Tamura, 1996, Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes, J Mol Cell Cardiol, 28, 1811, 10.1006/jmcc.1996.0170 Cheung, 1998, Natriuretic peptides—relevance in cardiovascular disease, JAMA, 280, 1983, 10.1001/jama.280.23.1983 Nakamura, 1991, Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes, Am J Hypertens, 4, 909, 10.1093/ajh/4.11.909 Wei, 1993, Natriuretic peptide system in human heart failure, Circulation, 88, 1004, 10.1161/01.CIR.88.3.1004 Hasegawa, 1993, Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy, Circulation, 88, 372, 10.1161/01.CIR.88.2.372 Hasegawa, 1993, Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy, Am J Pathol, 142, 107 Hunt, 1997, The role of the circulation in processing pro-Brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32, Peptides, 18, 1475, 10.1016/S0196-9781(97)00245-3 Clerico, 1999, Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans, Horm Metab Res, 31, 487, 10.1055/s-2007-978782 Jensen, 1997, A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases, Scand J Clin Lab Invest, 57, 529, 10.3109/00365519709084604 Pedersen, 1999, Pulsatile secretion of atrial natriuretic peptide and brain natriuretic peptide in healthy humans, Clin Sci, 97, 201, 10.1042/cs0970201 de Bold, 1996, Mechanical and neuroendocrine regulation of the endocrine heart, Cardiovasc Res, 31, 7, 10.1016/S0008-6363(95)00121-2 Magga, 1997, Involvement of transcriptional and posttranscriptional mechanisms in cardiac overload-induced increase of B-type natriuretic peptide gene expression, Circ Res, 81, 694, 10.1161/01.RES.81.5.694 Sugawara, 1988, Cosecretion of peptides derived from gamma-human atrial natriuretic polypeptide in normal volunteers and patients with essential hypertension and adrenal disorders, J Hypertension, 6, S327, 10.1097/00004872-198812040-00101 Lang, 1993, The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in man, J Hypertension, 11, 737, 10.1097/00004872-199307000-00009 Naruse, 1994, Atrial and brain natriuretic peptides in cardiovascular diseases, Hypertension, 23, I-231, 10.1161/01.HYP.23.1_Suppl.I231 Lang, 1991, Dietary sodium loading increases plasma brain natriuretic peptide levels in man, J. Hypertension, 9, 779, 10.1097/00004872-199109000-00002 Buckley, 1994, Brain and atrial natriuretic peptides, J. Hypertension, 12, 809, 10.1097/00004872-199407000-00013 Yamazaki, 2000, Plasma brain natriuretic peptide in athletes, Am J Cardiol, 85, 1393, 10.1016/S0002-9149(00)00781-5 Wijbenga, 1999, Cardiac peptides differ in their response to exercise, Eur Heart J, 20, 1424, 10.1053/euhj.1999.1630 Friedl, 1999, Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise, Clinica Chimica Acta, 281, 121, 10.1016/S0009-8981(98)00217-4 Matsumoto, 1995, Effects of exercise on plasma levels of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction, Am Heart J, 129, 139, 10.1016/0002-8703(95)90054-3 Kyriakides, 2000, Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty, Clin Cardiol, 23, 285, 10.1002/clc.4960230412 Tateishi, 2000, Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty, Clin Cardiol, 23, 776, 10.1002/clc.4960231016 Malatino, 1992, Transient myocardial ischemia stimulates atrial natriuretic factor release, Am Heart J, 123, 693, 10.1016/0002-8703(92)90508-S Nigri, 1996, Atrial natriuretic peptide during myocardial ischemia induced by percutaneous transluminal coronary angioplasty, Am Heart J, 132, 698, 10.1016/S0002-8703(96)90261-6 Kikuta, 1996, Increased plasma levels of B-type natriuretic peptide in patients with unstable angina, Am Heart J, 132, 101, 10.1016/S0002-8703(96)90396-8 Nakagawa, 1995, Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy, J Clin Invest, 96, 1280, 10.1172/JCI118162 Liang, 1997, Mechanical strain increases expression of the brain natriuretic peptide gene in rat cardiac myocytes, J Biol Chem, 272, 28050, 10.1074/jbc.272.44.28050 Mantymaa, 1993, Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro, Endocrinology, 133, 1470, 10.1210/endo.133.3.8365376 Doyama, 1998, Expression and distribution of brain natriuretic peptide in human right atria, J Am Coll Cardiol, 32, 1832, 10.1016/S0735-1097(98)00494-X Magga, 1994, Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats, Endocrinology, 134, 2505, 10.1210/endo.134.6.8194476 Durocher, 1998, Regulation of gene expression in the endocrine heart, Recent Prog Horm Res, 53, 7 Yoshibayashi, 1995, Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence, Eur J Endocrinol, 133, 207, 10.1530/eje.0.1330207 Nagaya, 1998, Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension, J Am Coll Cardiol, 31, 202, 10.1016/S0735-1097(97)00452-X Maack, 1992, Receptors of atrial natriuretic factor, Annu Rev Physiol, 54, 11, 10.1146/annurev.ph.54.030192.000303 Jamison, 1992, The natriuretic peptides and their receptors, Am J Kid Dis, 20, 519, 10.1016/S0272-6386(12)70269-X Nakao, 1992, Molecular biology and biochemistry of the natriuretic peptide system. II, J. Hypertension, 10, 1111, 10.1097/00004872-199210000-00002 Suga, 1992, Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide, Endocrinology, 130, 229, 10.1210/endo.130.1.1309330 Fuller, 1988, Atrial natriuretic peptide clearance receptor, J Biol Chem, 263, 9395, 10.1016/S0021-9258(19)76554-5 Levin, 1993, Natriuretic peptide C-receptor, Am J Physiol, 264, E483 Chang, 1989, Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases, Nature, 341, 68, 10.1038/341068a0 Chinkers, 1989, A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor, Nature, 338, 78, 10.1038/338078a0 Koller, 1992, Molecular biology of the natriuretic peptides and their receptors, Circulation, 86, 1081, 10.1161/01.CIR.86.4.1081 Anand-Srivastava, 1997, Atrial natriuretic peptide-C receptor and membrane signalling in hypertension, J Hypertension, 15, 815, 10.1097/00004872-199715080-00004 Hempel, 1998, Atrial natriuretic peptide clearance receptor participates in modulating endothelial permeability, Am J Physiol, 275, H1818 Yoshimura, 1991, Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure, Circulation, 84, 1581, 10.1161/01.CIR.84.4.1581 McGregor, 1990, Brain natriuretic peptide administered to man, J Clin Endocrinol Metab, 70, 1103, 10.1210/jcem-70-4-1103 La Villa, 1994, Cardiovascular and renal effects of low dose brain natriuretic peptide infusion in man, J Clin Endocrinol Metab, 78, 1166 Jensen, 1998, Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans, Am J Physiol, 274, F63 Akabane, 1991, Effects of brain natriuretic peptide on renin secretion in normal and hypertonic saline-infused kidney, Eur J Pharmacol, 198, 143, 10.1016/0014-2999(91)90613-U Hashiguchi, 1989, Effect of porcine brain natriuretic peptide (pBNP) on human adrenocortical steroidogenesis, Clin Endocrinol, 31, 623, 10.1111/j.1365-2265.1989.tb01287.x Torda, 1989, Brain natriuretic peptide receptors in the rat peripheral sympathetic ganglia, Biochem Biophys Res Commun, 159, 1032, 10.1016/0006-291X(89)92212-2 Morita, 1989, Effects of brain natriuretic peptide on renal nerve activity in conscious rabbits, Am J Physiol, 256, R792 Tamura, 2000, Cardiac fibrosis in mice lacking brain natriuretic peptide, Proc Natl Acad Sci, 97, 4239, 10.1073/pnas.070371497 Schirger, 2000, Vascular actions of brain natriuretic peptide, J Am Coll Cardiol, 35, 796, 10.1016/S0735-1097(99)00593-8 Yoshizumi, 1999, Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells, Thromb Haemost, 82, 1497, 10.1055/s-0037-1614861 Tanaka, 1993, Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectoris, Am J Cardiol, 72, 128, 10.1016/0002-9149(93)90147-5 Kato, 1994, Suppression of hyperventilation-induced attacks with infusion of B-type (brain) natriuretic peptide in patients with variant angina, Am Heart J, 128, 1098, 10.1016/0002-8703(94)90739-0 Cargill, 1995, Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans, Thorax, 50, 183, 10.1136/thx.50.2.183 Cargill, 1996, Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale, Chest, 110, 1220, 10.1378/chest.110.5.1220 Soleilhac, 1992, A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium, Mol Pharmacol, 41, 609 Lainchbury, 1998, Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man, Clin Sci, 95, 547, 10.1042/cs0950547 Hollister, 1989, Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog, J Clin Invest, 83, 623, 10.1172/JCI113926 Mards, 1993, Brain natriuretic factor, Br Heart J, 69, 414, 10.1136/hrt.69.5.414 Crozier, 1986, Atrial natriuretic peptide in humans, Hypertension, 8, II-11, 10.1161/01.HYP.8.6_Pt_2.II11 Pemberton, 1998, Amino-terminal proBNP in ovine plasma, Am J Physiol, 275, H1200 Luchner, 1998, Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism, JACC, 32, 1839, 10.1016/S0735-1097(98)00478-1 Yoshimura, 1994, Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure, Br Heart J, 72, 528, 10.1136/hrt.72.6.528 Missouris, 1998, How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines, Clin Sci, 94, 591, 10.1042/cs0940591 Sagnella, 1998, Measurement and significance of circulating natriuretic peptides in cardiovascular disease, Clin Sci, 95, 519, 10.1042/cs0950519 Clerico, 2000, Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice, Clin Chemistry, 46, 1529, 10.1093/clinchem/46.10.1529 Bevilacqua, 1997, Analytical agreement and clinical correlates of plasma brain natriuretic peptide measured by three immunoassays in patients with heart failure, Clin Chemistry, 43, 2439, 10.1093/clinchem/43.12.2439 Buckley, 1999, Cardiac peptide stability, aprotonin and room temperature, Clin Sci, 97, 689, 10.1042/cs0970689 Davidson, 1995, N-terminal Proatrial natriuretic peptide and brain natriuretic peptide are stable for up to 6 hours in whole blood in vitro, Circulation, 91, 1276 Murdoch, 1998, Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay, Heart, 78, 594, 10.1136/hrt.78.6.594 Downie, 1999, Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro, Clin Sci, 97, 255, 10.1042/cs0970255 Karl, 1999, Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit, Scand J Clin Lab Invest, 59, P177, 10.1080/00365519909168341 Flesicher, 1997, Rapid assay of plasma brain natriuretic peptide in the assessment of acute dyspnoea, N Z Med J, 110, 71 Clerico, 1991, Evaluation of the analytical performance of RIA methods for measurement of ANP, J Clin Immunoassay, 14, 251 Kono, 1993, An immunoradiometric assay for brain natriuretic peptide in human plasma, Kaku Igaku, 13, 2 Clerico, 1998, Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with differing degrees of heart failure, J Endocrinol Invest, 21, 170, 10.1007/BF03347297 Valli, 1999, Review of 10 years of the clinical use of brain natriuretic peptide in cardiology, J Lab Clin Med, 134, 437, 10.1016/S0022-2143(99)90163-4 Vogeser, 2001, B-type Natriuretic Peptide (BNP)—Validation of an immediate response assay, Clin Lab, 47, 29 Maisel, 2001, Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction, Am Heart J, 141, 367, 10.1067/mhj.2001.113215 Hunt, 1995, The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma, Biochem Biophys Res Commun, 214, 1175, 10.1006/bbrc.1995.2410 Hughes, 1999, An immunoluminometric assay for N-terminal pro-brain natriuretic peptide, Clin Sci, 96, 373, 10.1042/cs0960373 Puschendorf, 1998, Cardiac diseases, 101 Wallen, 1997, Brain natriuretic peptide in an elderly population, J Intern Med, 242, 307, 10.1046/j.1365-2796.1997.00184.x Richards, 1998, Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin, Circulation, 97, 1921, 10.1161/01.CIR.97.19.1921 Remes, 1991, Validity of clinical diagnosis of heart failure in primary health care, Eur Heart J, 12, 315, 10.1093/oxfordjournals.eurheartj.a059896 Cowie, 1999, Incidence and aetiology of heart failure, Eur Heart J, 20, 421, 10.1053/euhj.1998.1280 Fox, 2001, Coronary artery disease as the cause of incident heart failure in the population, Eur Heart J, 22, 228, 10.1053/euhj.2000.2289 1995, Guidelines for the diagnosis of heart failure, Eur Heart J, 16, 741 Cheitlin, 1997, ACC/AHA Guidelines for the clinical application of echocardiography, Circulation, 95, 1686, 10.1161/01.CIR.95.6.1686 Mukoyama, 1990, Increased human brain natriuretic peptide in congestive heart failure, N Engl J Med, 323, 757, 10.1056/NEJM199009133231114 Cowie, 1997, Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care, Lancet, 350, 1349, 10.1016/S0140-6736(97)06031-5 Davis, 1994, Plasma brain natriuretic peptide in assessment of acute dyspnoea, Lancet, 343, 440, 10.1016/S0140-6736(94)92690-5 Fleischer, 1997, Rapid assay of plasma brain natriuretic peptide in the assessment of acute dyspnoea, N Z Med J, 110, 71 Dao, 2001, Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting, J Am Coll Cardio, 37, 379, 10.1016/S0735-1097(00)01156-6 2001, Guidelines for the diagnosis and treatment of chronic heart failure, Eur Heart J, 22, 1527, 10.1053/euhj.2001.2783 Cowie, 1997, The epidemiology of heart failure, Eur Heart J, 18, 208, 10.1093/oxfordjournals.eurheartj.a015223 Cowie, 1999, Annotated references in epidemiology, Eur J Heart Failure, 1, 101, 10.1016/S1388-9842(98)00008-7 Yoshimura, 1993, Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure, Circulation, 87, 464, 10.1161/01.CIR.87.2.464 Talwar, 2001, Plasma N-terminal proBNP and cardiotrophin-1 are elevated in aortic stenosis, Eur J Heart Failure, 3, 15, 10.1016/S1388-9842(00)00074-X Ikeda, 1997, Plasma levels of brain natriuretic peptide and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis, Am Heart J, 133, 307, 10.1016/S0002-8703(97)70225-4 Prasad, 1997, Brain natriuretic peptide concentrations in patients with aortic stenosis, Am Heart J, 133, 477, 10.1016/S0002-8703(97)70196-0 Lang, 1994, Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction, Am Heart J, 127, 1635, 10.1016/0002-8703(94)90401-4 Selvais, 1998, Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure, Eur J Clin Invest, 28, 636, 10.1046/j.1365-2362.1998.00338.x Hunt, 1997, Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-ProBNP), Clin Endocrinol, 47, 287, 10.1046/j.1365-2265.1997.2361058.x Yoshimura, 2000, Interaction on metabolic clearance between A-type and B-type natriuretic peptides in patients with heart failure, Metabolism, 49, 1228, 10.1053/meta.2000.8602 Omland, 1996, Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment, Heart, 76, 232, 10.1136/hrt.76.3.232 Maeda, 1998, Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction, Am Heart J, 135, 825, 10.1016/S0002-8703(98)70041-9 Davidson, 1996, Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction, Am J Cardiol, 77, 828, 10.1016/S0002-9149(97)89176-X Groenning, 2001, Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neuro-hormonal plasma concentrations, Eur J Heart Failure, 3, 699, 10.1016/S1388-9842(01)00181-7 Hammerer-Lercher, 2001, Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction, Clinica Chimica Acta, 310, 193, 10.1016/S0009-8981(01)00578-2 Fruhwald, 1999, Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy, Eur Heart J, 20, 1415, 10.1053/euhj.1999.1633 Yu, 1996, Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern, Eur Heart J, 17, 1694, 10.1093/oxfordjournals.eurheartj.a014753 Tresch, 1995, Heart failure with normal systolic function, J Am Geri Soc, 43, 1035, 10.1111/j.1532-5415.1995.tb05570.x Vasan, 1995, Prevalence, clinical features and prognosis of diastolic heart failure, JACC, 26, 1565, 10.1016/0735-1097(95)00381-9 Horio, 1993, Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty, Am Heart J, 126, 293, 10.1016/0002-8703(93)91042-D Arakawa, 1994, Relationships between plasma level of brain natriuretic peptide and myocardial infarct size, Cardiology, 85, 334, 10.1159/000176706 Uusimaa, 1999, Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction, Int J Cardiol, 69, 5, 10.1016/S0167-5273(99)00007-8 Morita, 1993, Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction, Circulation, 88, 82, 10.1161/01.CIR.88.1.82 Motwani, 1993, Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction, Lancet, 341, 1109, 10.1016/0140-6736(93)93126-L Choy, 1994, Detection of left ventricular dysfunction after acute myocardial infarction, Br Heart J, 72, 16, 10.1136/hrt.72.1.16 Omland, 1996, Plasma brain natriuretic peptide as an indicator of left ventricular systolic dysfunction and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide, Circulation, 93, 1963, 10.1161/01.CIR.93.11.1963 McClure, 1998, Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care, BMJ, 317, 516, 10.1136/bmj.317.7157.516 Nagaya, 1999, Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventricular remodelling after acute myocardial infarction, Clin Sci, 96, 129, 10.1042/cs0960129 Ryan, 1999, American College of Cardiology/American Heart Association guidelines for the management of patients with acute myocardial infarction, J Am Coll Cardiol, 34, 890, 10.1016/S0735-1097(99)00351-4 Julian, 1996, Acute myocardial infarction, Eur Heart J, 17, 43, 10.1093/oxfordjournals.eurheartj.a014691 McMurray, 1998, Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?, Eur Heart J, 19, 842, 10.1093/eurheartj/19.6.842 Nielsen, 2001, Screening by brain natriuretic peptide is cost effective to detect left ventricular systolic dysfunction in subjects at risk in general practice, Eur J Heart Failure, 3, S1 Suzuki, 2000, Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels, Jpn Heart J, 41, 205, 10.1536/jhj.41.205 McDonagh, 1998, Biochemical detection of left-ventricular systolic dysfunction, Lancet, 351, 9, 10.1016/S0140-6736(97)03034-1 Smith, 2000, Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice, BMJ, 320, 906, 10.1136/bmj.320.7239.906 Hetmanski, 2000, Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community, Heart, 84, 440, 10.1136/heart.84.4.440 Luchner, 2000, Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population, J Hypertension, 18, 1121, 10.1097/00004872-200018080-00018 Niinuma, 1998, Plasma B-type natriuretic peptide measurement in a multiphasic health screening program, Cardiology, 90, 89, 10.1159/000006825 Von Hoff, 1979, Risk factors for doxorubicin-induced congestive heart failure, Ann Intern Med, 91, 710, 10.7326/0003-4819-91-5-710 Bauch, 1992, Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects, Cancer, 69, 1492, 10.1002/1097-0142(19920315)69:6<1492::AID-CNCR2820690630>3.0.CO;2-3 Neri, 1991, Preliminary study on behaviour of atrial natriuretic factor in anthracycline-related cardiac toxicity, Int J Clin Pharmacol Res, 11, 75 Nousiainen, 1999, Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma, Eur J Haematol, 62, 135, 10.1111/j.1600-0609.1999.tb01734.x Tulevski, 2001, Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload, Heart, 86, 27, 10.1136/heart.86.1.27 Matsuo, 1998, Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia, Circulation, 98, 2433, 10.1161/01.CIR.98.22.2433 Gottlieb, 1989, Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure, J Am Coll Cardiol, 13, 1534, 10.1016/0735-1097(89)90344-6 Swedberg, 1990, Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality, Circulation, 82, 1730, 10.1161/01.CIR.82.5.1730 Rouleau, 1994, Prognostic value of neurohormonal activation in patients with acute myocardial infarction, J Am Coll Cardio, 24, 583, 10.1016/0735-1097(94)90001-9 Tsutamoto, 1995, Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure, Am J Cardiol, 76, 803, 10.1016/S0002-9149(99)80231-8 Tsutamoto, 1997, Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure, Circulation, 96, 509, 10.1161/01.CIR.96.2.509 Tsutamoto, 1999, Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction, Eur Heart J, 20, 1799, 10.1053/euhj.1999.1746 Cowie, 2000, N-Terminal Pro-BNP predicts prognosis in patients presenting with heart failure for the first time better than does N-terminal Pro-ANP or BNP, Circulation, 102, II-781 Cheng, 2001, A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure, J Am Coll Cardiol, 37, 386, 10.1016/S0735-1097(00)01157-8 Arakawa, 1996, Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction, J Am Coll Cardiol, 27, 1656, 10.1016/0735-1097(96)00067-8 Darbar, 1996, Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction, Am J Cardiol, 78, 284, 10.1016/S0002-9149(96)00278-0 McDonagh, 2001, Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population, Heart, 86, 21, 10.1136/heart.86.1.21 Wallen, 1997, Brain natriuretic peptide predicts mortality in the elderly, Heart, 77, 264, 10.1136/hrt.77.3.264 Wallen, 1997, Atrial natriuretic peptides predict mortality in the elderly, J Intern Med, 241, 269, 10.1046/j.1365-2796.1997.128149000.x Davis, 1992, Atrial natriuretic peptide levels in the prediction of congestive heart failure in frail elderly, JAMA, 267, 2625, 10.1001/jama.1992.03480190067033 Nagaya, 2000, Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension, Circulation, 102, 865, 10.1161/01.CIR.102.8.865 1999, Consensus recommendations for the management of chronic heart failure, Am J Cardiol, 83, 1A 1997, The treatment of heart failure, Eur Heart J, 18, 736, 10.1093/oxfordjournals.eurheartj.a015339 Diagnosis and treatment of heart failure due to left ventricular systolic dysfunction: A National Clinical Guidelines. Guideline 35. 1999, Edinburgh, Scottish Intercollegiate Guidelines Network. 99 Murdoch, 1999, Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration, Am Heart J, 138, 1126, 10.1016/S0002-8703(99)70079-7 Troughton, 2000, Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations, Lancet, 355, 1126, 10.1016/S0140-6736(00)02060-2 Richards, 1999, Neurohormonal prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group, Circulation, 99, 786, 10.1161/01.CIR.99.6.786 Richards, 2001, Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin, J Am Coll Cardiol, 37, 1781, 10.1016/S0735-1097(01)01269-4 Clemens, 1998, Pharmacokinetics and biological actions of subcutaneously administered human brain natriuretic peptide, J Pharm Exp Therap, 287, 67 Hobbs, 1996, Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, Am J Cardiol, 78, 896, 10.1016/S0002-9149(96)00464-X Marcus, 1996, Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure, Circulation, 94, 3184, 10.1161/01.CIR.94.12.3184 Abraham, 1998, Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure, J Card Fail, 4, 37, 10.1016/S1071-9164(98)90506-1 Colucci, 2001, Nesiritide for the treatment of decompensated heart failure, J Card Fail, 7, 92, 10.1054/jcaf.2001.22999 Mills, 1999, Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure, J Am Coll Cardiol, 34, 155, 10.1016/S0735-1097(99)00184-9 Colucci, 2000, Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group, N Engl J Med, 343, 246, 10.1056/NEJM200007273430403 Clarkson, 1996, Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure, Circulation, 93, 2037, 10.1161/01.CIR.93.11.2037 Lang, 1991, Influence of candoxatril on plasma brain natriuretic peptide in heart failure, Lancet, 338, 255, 10.1016/0140-6736(91)90397-8 Munzel, 1992, Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure, Circulation, 86, 1089, 10.1161/01.CIR.86.4.1089 Elsner, 1992, Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure, Am J Cardiol, 70, 494, 10.1016/0002-9149(92)91196-B Northridge, 1999, Comparison of the short-term effects of candoxatril, an orally active neutral endopeptidase inhibitor, and frusemide in the treatment of patients with chronic heart failure, Am Heart J, 138, 1149, 10.1016/S0002-8703(99)70082-7 Westheim, 1999, Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure, J Am Coll Cardiol, 34, 1794, 10.1016/S0735-1097(99)00435-0 Newby, 1998, Candoxatril improves exercise capacity in patients with chronic heart failure receiving angiotensin converting enzyme inhibition, Eur Heart J, 19, 1808, 10.1053/euhj.1998.1201 Northridge, 1999, Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure, Eur J Heart Failure, 1, 67, 10.1016/S1388-9842(98)00003-8 Kentsch, 1999, Novel neurohormonal modulators in cardiovascular disorders. The therapeutic potential of endopeptidase inhibitors, Drugs R D, 1, 331, 10.2165/00126839-199901040-00011 Robl, 1997, Dual metalloprotease inhibitors, J Med Chem, 40, 1570, 10.1021/jm970041e Burnett, 1999, Vasopeptidase inhibition, J Hypertension, 17, S37 McClean, 2000, The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure, J Am Coll Cardiol, 36, 479, 10.1016/S0735-1097(00)00741-5 Rouleau, 2000, Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure, Lancet, 356, 615, 10.1016/S0140-6736(00)02602-7 McClean, 2001, Effects of omapatrilat on systemic arterial function in patients with chronic heart failure, Am J Cardiol, 87, 565, 10.1016/S0002-9149(00)01432-6 Lang, 1992, Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease, Clin Sci, 83, 529, 10.1042/cs0830529 Bando, 1999, Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale, Resp Med, 93, 507, 10.1016/S0954-6111(99)90094-X Ando, 1996, Plasma concentrations of atrial, brain, and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory disease, Chest, 110, 462, 10.1378/chest.110.2.462 Kohno, 1992, Brain natriuretic peptide as a cardiac hormone in essential hypertension, Am J Med, 92, 29, 10.1016/0002-9343(92)90011-Y Kohno, 1995, Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy, Am J Med, 98, 257, 10.1016/S0002-9343(99)80372-6 Yasumoto, 1999, Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension, Am J Hypertens, 12, 921, 10.1016/S0895-7061(99)00062-X Prasad, 1995, Raised plasma concentrations of brain natriuretic peptide in pulmonary arterial hypertension, Resp Med, 89, 445, 10.1016/0954-6111(95)90215-5 Briguori, 2001, Determinants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy, Eur Heart J, 22, 1328, 10.1053/euhj.2000.2535 Ruskoaho, 1992, Atrial natriuretic peptide, Pharmacol Rev, 44, 481 Yamaji, 1988, Plasma levels of atrial natriuretic hormone in Cushing's syndrome, J Clin Endocrinol Metab, 67, 348, 10.1210/jcem-67-2-348 Lapinski, 1991, Plasma atrial natriuretic peptide concentration in patients with primary aldosteronism, J Hypertension, 9, S260 Yamaji, 1986, Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension, J Clin Endocrinol Metab, 63, 815, 10.1210/jcem-63-4-815 Cappuccio, 1989, Raised plasma levels of atrial natriuretic peptides in Addison's disease, J Endocrinol Invest, 12, 205, 10.1007/BF03349963 Zietse, 1997, Atrial natriuretic peptide in diabetic nephropathy, Kidney Int, 52, S-33 Straub, 1996, Atrial natriuretic factor and digoxin-like immunoreactive factor in diabetic patients, J Clin Endocrinol Metab, 81, 3385 Mau Perdersen, 1992, Determinants of intra-individual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients, Clin Sci, 83, 445, 10.1042/cs0830445 Yano, 1999, Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria, J Clin Endocrinol Metab, 84, 2353, 10.1210/jcem.84.7.5819 La Villa, 1995, Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention, Hepatology, 22, 1745, 10.1002/hep.1840220620 Akiba, 1995, Plasma human brain natriuretic peptide in chronic renal failure, Clin Nephrol, 44, S61 Hasegawa, 1986, Plasma levels of atrial natriuretic peptide in patients with chronic renal failure, J Clin Endocrinol Metab, 63, 819, 10.1210/jcem-63-4-819 Johnson, 1997, Ectopic production and processing of atrial natriuretic peptide in a small call lung carcinoma cell line and tumor from a patient with hyponatremia, Cancer, 79, 35, 10.1002/(SICI)1097-0142(19970101)79:1<35::AID-CNCR6>3.0.CO;2-L Marchioli, 1997, Paraneoplastic syndromes associated with small cell lung cancer, Chest Surg Clin North Am, 7, 65 Wijdicks, 1997, Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage, J Neurosurg, 87, 275, 10.3171/jns.1997.87.2.0275 Sviri, 2000, Brain natriuretic peptide and cerebral vasospasm in subarachnoid hemorrhage, Stroke, 31, 118, 10.1161/01.STR.31.1.118 Richards, 1999, Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group, Heart, 81, 114, 10.1136/hrt.81.2.114